Suppr超能文献

嫌色细胞肾细胞癌:新的遗传学和代谢见解。

Chromophobe renal cell carcinoma: New genetic and metabolic insights.

机构信息

Brigham and Women's Hospital, Boston, MA.

Brigham and Women's Hospital, Boston, MA.

出版信息

Urol Oncol. 2020 Aug;38(8):678-681. doi: 10.1016/j.urolonc.2020.04.035. Epub 2020 May 20.

Abstract

Chromophobe renal cell carcinoma (chRCC) represents 5% of all RCC. ChRCC appears to arise from the distal nephron, in contrast to clear cell RCC that arises from the proximal nephron. ChRCC is distinctive because the tumor cells contain abundant abnormal mitochondria, and frequently have loss of one copy of multiple chromosomes, with a low rate of somatic mutations. Here, we focus on recent discoveries related to genetic and metabolic factors that may promote the progression of chRCC and summarize how these findings may relate to the prognosis and treatment of chRCC.

摘要

嫌色细胞肾细胞癌(chRCC)占所有肾细胞癌的 5%。与起源于近端肾单位的透明细胞肾细胞癌不同,chRCC 似乎起源于远端肾单位。chRCC 的特点是肿瘤细胞含有丰富的异常线粒体,并且经常丢失多个染色体的一个拷贝,体细胞突变率低。在这里,我们重点介绍与遗传和代谢因素相关的最新发现,这些因素可能促进 chRCC 的进展,并总结这些发现与 chRCC 的预后和治疗的关系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验